Complete diagnostic tests and share your medical information

Back to Event Suggestive of Multiple Sclerosis trials

Recruiting

What is this trial?

Researchers want to compare two sets of diagnostic guidelines—one from 2024 and one from 2017—to see which one helps doctors diagnose multiple sclerosis more quickly and accurately in real patients. Both guidelines use brain scans and other tests to confirm MS, but the newer version may allow faster diagnosis. This study will help doctors know which approach works best for patients like you who are experiencing symptoms that could be multiple sclerosis.

Starting treatment early for multiple sclerosis can prevent long-term disability, but doctors often wait for a second symptom or test result before confirming the diagnosis. This causes delays that may hurt patients in the long run. This study will show whether using the newer diagnostic guidelines could help doctors diagnose MS sooner, so patients can begin treatment faster.

Do you qualify?

You likely qualify if…

you are seeing a neurologist at Nancy University Hospital or Metz-Thionville Regional Hospital for the first time
you are experiencing symptoms or have brain imaging that suggests multiple sclerosis
you are covered by French national health insurance
you are able to have at least one brain MRI scan during your initial evaluation

You likely don't qualify if…

your symptoms are caused by a different condition, such as neuromyelitis optica, sarcoidosis, or an infection
you cannot safely have a brain MRI (such as due to a pacemaker or metal implants)
your symptoms are thought to be caused by a vascular, tumor, or paraneoplastic disorder

What participation looks like

You will undergo standard diagnostic testing including brain MRI scans and other tests your neurologist recommends—these are tests you would normally receive anyway. Researchers will then review your medical records and test results to compare how well the two diagnostic guidelines identify MS in your case. You will not be taking any medication as part of this study; researchers are simply analyzing which diagnostic approach works better using information from your routine care.

Testing two diagnostic approaches for multiple sclerosis

What is this trial?

Do you qualify?

What participation looks like

Trial locations(2 sites)